How Can We Help You?


Quick Info:

Find a Doctor Specialties (800) 213-3284

Select Clinical Trial

Protocol Number: INSIGHT 013; NCT04546581

Protocol Title: An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19

Eligibility: Men and women age 18 and older requiring hospitalization for symptomatic COVID-19 disease.

Contact Information: (910) 715-220

Clara McLean House
Make a Donation
News & Events